Original Research6 September 2016
A Cohort Study
    Author, Article and Disclosure Information
    Background:

    The aggregation of misfolded proteins in the brain occurs in several neurodegenerative disorders. Aberrant protein aggregation is inducible in rodents and primates by intracerebral inoculation. Possible transfusion transmission of neurodegenerative diseases has important public health implications.

    Objective:

    To investigate possible transfusion transmission of neurodegenerative disorders.

    Design:

    Retrospective cohort study.

    Setting:

    Nationwide registers of transfusions in Sweden and Denmark.

    Participants:

    1 465 845 patients who received transfusions between 1968 and 2012.

    Measurements:

    Multivariable Cox regression models were used to estimate hazard ratios for dementia of any type, Alzheimer disease, and Parkinson disease in patients receiving blood transfusions from donors who were later diagnosed with any of these diseases versus patients who received blood from healthy donors. Whether excess occurrence of neurodegenerative disease occurred among recipients of blood from a subset of donors was also investigated. As a positive control, transmission of chronic hepatitis before and after implementation of hepatitis C virus screening was assessed.

    Results:

    Among included patients, 2.9% received a transfusion from a donor diagnosed with one of the studied neurodegenerative diseases. No evidence of transmission of any of these diseases was found, regardless of approach. The hazard ratio for dementia in recipients of blood from donors with dementia versus recipients of blood from healthy donors was 1.04 (95% CI, 0.99 to 1.09). Corresponding estimates for Alzheimer disease and Parkinson disease were 0.99 (CI, 0.85 to 1.15) and 0.94 (CI, 0.78 to 1.14), respectively. Hepatitis transmission was detected before but not after implementation of hepatitis C virus screening.

    Limitation:

    Observational study design, underascertainment of the outcome, and possible insufficient statistical power.

    Conclusion:

    The data provide no evidence for the transmission of neurodegenerative diseases and suggest that if transmission does occur, it is rare.

    Primary Funding Source:

    Swedish Research Council, Swedish Heart-Lung Foundation, Swedish Society for Medical Research, and Danish Council for Independent Research.

    References

    • 1. Lee SJ Desplats P Sigurdson C Tsigelny I Masliah E Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol2010;6:702-6. [PMID: 21045796] doi:10.1038/nrneurol.2010.145 CrossrefMedlineGoogle Scholar
    • 2. Morales R Duran-Aniotz C Castilla J Estrada LD Soto C De novo induction of amyloid-ß deposition in vivo. Mol Psychiatry2012;17:1347-53. [PMID: 21968933] doi:10.1038/mp.2011.120 CrossrefMedlineGoogle Scholar
    • 3. Prusiner SB Cell biology. A unifying role for prions in neurodegenerative diseases. Science2012;336:1511-3. [PMID: 22723400] doi:10.1126/science.1222951 CrossrefMedlineGoogle Scholar
    • 4. Münch C O'Brien J Bertolotti A Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A2011;108:3548-53. [PMID: 21321227] doi:10.1073/pnas.1017275108 CrossrefMedlineGoogle Scholar
    • 5. Grad LI Yerbury JJ Turner BJ Guest WC Pokrishevsky E O'Neill MA et alIntercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A2014;111:3620-5. [PMID: 24550511] doi:10.1073/pnas.1312245111 CrossrefMedlineGoogle Scholar
    • 6. Jucker M Walker LC Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature2013;501:45-51. [PMID: 24005412] doi:10.1038/nature12481 CrossrefMedlineGoogle Scholar
    • 7. Sanders DW Kaufman SK DeVos SL Sharma AM Mirbaha H Li A et alDistinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron2014;82:1271-88. [PMID: 24857020] doi:10.1016/j.neuron.2014.04.047 CrossrefMedlineGoogle Scholar
    • 8. Polymenidou M Cleveland DW The seeds of neurodegeneration: prion-like spreading in ALS. Cell2011;147:498-508. [PMID: 22036560] doi:10.1016/j.cell.2011.10.011 CrossrefMedlineGoogle Scholar
    • 9. Kim J Holtzman DM Medicine. Prion-like behavior of amyloid-beta. Science2010;330:918-9. [PMID: 21071652] doi:10.1126/science.1198314 CrossrefMedlineGoogle Scholar
    • 10. Frost B Diamond MI Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci2010;11:155-9. [PMID: 20029438] doi:10.1038/nrn2786 CrossrefMedlineGoogle Scholar
    • 11. Olanow CW Stern MB Sethi K The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology2009;72:S1-136. [PMID: 19470958] doi:10.1212/WNL.0b013e3181a1d44c CrossrefMedlineGoogle Scholar
    • 12. Frost B Jacks RL Diamond MI Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem2009;284:12845-52. [PMID: 19282288] doi:10.1074/jbc.M808759200 CrossrefMedlineGoogle Scholar
    • 13. Meyer-Luehmann M Coomaraswamy J Bolmont T Kaeser S Schaefer C Kilger E et alExogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science2006;313:1781-4. [PMID: 16990547] CrossrefMedlineGoogle Scholar
    • 14. Ridley RM Baker HF Windle CP Cummings RM Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm (Vienna)2006;113:1243-51. [PMID: 16362635] CrossrefMedlineGoogle Scholar
    • 15. Baker HF Ridley RM Duchen LW Crow TJ Bruton CJ Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol1994;8:25-39. [PMID: 8086126] CrossrefMedlineGoogle Scholar
    • 16. Luk KC Kehm V Carroll J Zhang B O'Brien P Trojanowski JQ et alPathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science2012;338:949-53. [PMID: 23161999] doi:10.1126/science.1227157 CrossrefMedlineGoogle Scholar
    • 17. Clavaguera F Akatsu H Fraser G Crowther RA Frank S Hench J et alBrain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A2013;110:9535-40. [PMID: 23690619] doi:10.1073/pnas.1301175110 CrossrefMedlineGoogle Scholar
    • 18. Eisele YS Obermüller U Heilbronner G Baumann F Kaeser SA Wolburg H et alPeripherally applied Aβ-containing inoculates induce cerebral β-amyloidosis. Science2010;330:980-2. [PMID: 20966215] doi:10.1126/science.1194516 CrossrefMedlineGoogle Scholar
    • 19. Houston F Foster JD Chong A Hunter N Bostock CJ Transmission of BSE by blood transfusion in sheep [Letter]. Lancet2000;356:999-1000. [PMID: 11041403] CrossrefMedlineGoogle Scholar
    • 20. Llewelyn CA Hewitt PE Knight RS Amar K Cousens S Mackenzie J et alPossible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet2004;363:417-21. [PMID: 14962520] CrossrefMedlineGoogle Scholar
    • 21. Wroe SJ Pal S Siddique D Hyare H Macfarlane R Joiner S et alClinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet2006;368:2061-7. [PMID: 17161728] CrossrefMedlineGoogle Scholar
    • 22. Jaunmuktane Z Mead S Ellis M Wadsworth JD Nicoll AJ Kenny J et alEvidence for human transmission of amyloid-ß pathology and cerebral amyloid angiopathy. Nature2015;525:247-50. [PMID: 26354483] doi:10.1038/nature15369 CrossrefMedlineGoogle Scholar
    • 23. Ferri CP Prince M Brayne C Brodaty H Fratiglioni L Ganguli M et alAlzheimer's Disease InternationalGlobal prevalence of dementia: a Delphi consensus study. Lancet2005;366:2112-7. [PMID: 16360788] CrossrefMedlineGoogle Scholar
    • 24. Rodríguez-Leyva I Calderón-Garcidueñas AL Jiménez-Capdeville ME Rentería-Palomo AA Hernandez-Rodriguez HG Valdés-Rodríguez R et alα-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism. Ann Clin Transl Neurol2014;1:471-8. [PMID: 25356418] doi:10.1002/acn3.78 CrossrefMedlineGoogle Scholar
    • 25. Rodriguez-Leyva I Chi-Ahumada E Calderon-Garcidueñas AL Medina-Mier V Martel-Gallegos G Zarazua S et alSkin cells express altered proteins that characterize the most common neurodegenerative diseases. Neurology2015;83 Suppl 14 1. Google Scholar
    • 26. Kamper-Jørgensen M Edgren G Rostgaard K Biggar RJ Nyrén O Reilly M et alBlood transfusion exposure in Denmark and Sweden. Transfusion2009;49:888-94. [PMID: 19210324] doi:10.1111/j.1537-2995.2008.02081.x CrossrefMedlineGoogle Scholar
    • 27. Edgren G Rostgaard K Vasan SK Wikman A Norda R Pedersen OB et alThe new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility. Transfusion2015;55:1600-6. [PMID: 25573303] doi:10.1111/trf.12986 CrossrefMedlineGoogle Scholar
    • 28. Ludvigsson JF Otterblad-Olausson P Pettersson BU Ekbom A The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol2009;24:659-67. [PMID: 19504049] doi:10.1007/s10654-009-9350-y CrossrefMedlineGoogle Scholar
    • 29. Schmidt M Pedersen L Sørensen HT The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol2014;29:541-9. [PMID: 24965263] doi:10.1007/s10654-014-9930-3 CrossrefMedlineGoogle Scholar
    • 30. Edgren G Hjalgrim H Reilly M Tran TN Rostgaard K Shanwell A et alRisk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet2007;369:1724-30. [PMID: 17512857] CrossrefMedlineGoogle Scholar
    • 31. Hjalgrim H Rostgaard K Vasan SK Ullum H Erikstrup C Pedersen OB et alNo evidence of transmission of chronic lymphocytic leukemia through blood transfusion. Blood2015;126:2059-61. [PMID: 26302757] doi:10.1182/blood-2015-03-632844 CrossrefMedlineGoogle Scholar
    • 32. Schreiber GB Busch MP Kleinman SH Korelitz JJ The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med1996;334:1685-90. [PMID: 8637512] CrossrefMedlineGoogle Scholar
    • 33. Hinchliffe SR Lambert PC Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions. BMC Med Res Methodol2013;13:13. [PMID: 23384310] doi:10.1186/1471-2288-13-13 CrossrefMedlineGoogle Scholar
    • 34. Douet JY Zafar S Perret-Liaudet A Lacroux C Lugan S Aron N et alDetection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg Infect Dis2014;20:114-7. [PMID: 24377668] doi:10.3201/eid2001.130353 CrossrefMedlineGoogle Scholar
    • 35. Jin YP Gatz M Johansson B Pedersen NL Sensitivity and specificity of dementia coding in two Swedish disease registries. Neurology2004;63:739-41. [PMID: 15326258] CrossrefMedlineGoogle Scholar
    • 36. Phung TK Andersen BB Høgh P Kessing LV Mortensen PB Waldemar G Validity of dementia diagnoses in the Danish hospital registers. Dement Geriatr Cogn Disord2007;24:220-8. [PMID: 17690555] CrossrefMedlineGoogle Scholar
    • 37. Greenland S Lash TL Disease misclassification.. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008:358-9. Google Scholar
    • 38. Dorsey K Zou S Schonberger LB Sullivan M Kessler D Notari E 4th et alLack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion2009;49:977-84. [PMID: 19170987] doi:10.1111/j.1537-2995.2008.02056.x CrossrefMedlineGoogle Scholar